Evidence map›Paper›PMID 19474109›Full record

ArticleJournal of virology2009

Mutations that increase DNA binding by the processivity factor of herpes simplex virus affect virus production and DNA replication fidelity.

Changying Jiang, Gloria Komazin-Meredith, Wang Tian, Donald M Coen, Charles B C Hwang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Herpes simplex viruses: mechanisms of DNA replication.Cold Spring Harbor perspectives in biology · 2012
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Changying JiangDepartment of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.
Gloria Komazin-Meredith
Wang Tian
Donald M Coen
Charles B C Hwang
SUNY Upstate Medical University · USHarvard University · US

Funding

Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug TargetingR01AI026077 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI COEN, DONALD M · 1999 to 2019
$10.9M
MOLECULAR GENETICS OF HSV DNA POLYMERASE GENER01AI019838 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI COEN, DONALD M, HOGLE, JAMES M · 1985 to 2015
$5.9M
Fidelity of Herpes Simplex Virus DNA ReplicationR01AI056359 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI HWANG, CHARLES BIH-CHEN · 2004 to 2008
$1.4M
Molecular Genetics of HSV DNA Polymerase GeneR56AI019838 · NIAID · HARVARD MEDICAL SCHOOL · PI COEN, DONALD M · 2017 to 2017
$624k
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug TargetingR56AI026077 · NIAID · HARVARD MEDICAL SCHOOL · PI COEN, DONALD M, HOGLE, JAMES M · 2009 to 2009
$532k
Fidelity of Herpes Simplex Virus DNA ReplicationR21AI056359 · NIAID · UPSTATE MEDICAL UNIVERSITY · PI HWANG, CHARLES BIH-CHEN · 2003 to 2003
$334k
COMBINED APPROACH TO TARGETED ANTIHERPESVIRUS DRUGSU01AI026077 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI COEN, DONALD M · 1988 to 1998
–
NIAID NIH HHS AI019838NIAID NIH HHS AI026077NIAID NIH HHS AI056359NIAID NIH HHS R01 AI019838NIAID NIH HHS R01 AI026077NIAID NIH HHS R01 AI056359NIAID NIH HHS R21 AI056359NIAID NIH HHS R56 AI019838NIAID NIH HHS R56 AI026077
6 · The paper itself

Abstract

The interactions of the herpes simplex virus processivity factor UL42 with the catalytic subunit of the viral polymerase (Pol) and DNA are critical for viral DNA replication. Previous studies, including one showing that substitution of glutamine residue 282 with arginine (Q282R) results in an increase of DNA binding in vitro, have indicated that the positively charged back surface of UL42 interacts with DNA. To investigate the biological consequences of increased DNA binding by UL42 mutations, we constructed two additional UL42 mutants, including one with a double substitution of alanine for aspartic acid residues (D270A/D271A) and a triple mutant with the D270A/D271A and Q282R substitutions. These UL42 mutants exhibited increased and prolonged DNA binding without an effect on binding to a peptide corresponding to the C terminus of Pol. Plasmids expressing any of the three UL42 mutants with an increased positive charge on the back surface of UL42 were qualitatively competent for complementation of growth and DNA replication of a UL42 null mutant on Vero cells. We then engineered viruses expressing these mutant proteins. The UL42 mutants were more resistant to detergent extraction than wild-type UL42, suggesting that they are more tightly associated with DNA in infected cells. All three UL42 mutants formed smaller plaques on Vero cells and replicated to reduced yields compared with results for a control virus expressing wild-type UL42. Moreover, mutants with double and triple mutations, which contain D270A/D271A mutations, exhibited increased mutation frequencies, and mutants containing the Q282R mutation exhibited elevated ratios of virion DNA copies per PFU. These results suggest that herpes simplex virus has evolved so that UL42 neither binds DNA too tightly nor too weakly to optimize virus production and replication fidelity.

Indexed as

DNA ReplicationMutationVirus ReplicationAnimalsChlorocebus aethiopsDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA, ViralExodeoxyribonucleasesHerpes SimplexSimplexvirusVero CellsViral ProteinsDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA polymerase, SimplexvirusDNA, ViralExodeoxyribonucleasesViral Proteins

Identifiers

PMID19474109
PMCPMC2708624
OpenAlexW2124045117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.